CURE LEUKAEMIA
Relief of persons suffering from leukaemia by funding new therapies, treatments and research into and trials of such treatments and providing personnel and facilities for such purposes. Enabling co-operation of scientists and clinicians to develop new and effective treatments for leukaemia. Providing resources information and support groups for leukaemia patients and their families.
Objects
(I) THE RELIEF OF PERSONS SUFFERING FROM LEUKAEMIA.(II) TO UNDERTAKE RESEARCH INTO THE CAUSES, PREVENTION AND TREATMENT OF LEUKAEMIA AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net surplus of £105,278 for the year ended 31 October 2025, with total unrestricted funds carried forward amounting to £563,068. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and believe no material uncertainties exist regarding going concern. The charity's reserves policy aims to maintain free reserves equivalent to between 6 and 12 months of unrestricted expenditure.
What the accounts disclose
“The charity would like to maintain unrestricted funds not committed or invested in tangible fixed assets, which are the free reserves of the charity, at a level which equates to between 6- and 12-months unrestricted expenditure.” — page 6
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/10/2025
- Volunteers: 50
- Employees paid over £60,000: 3 (£60,001–£70,000: 2; £150,001–£200,000: 1)
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/10/2024
- Volunteers: 50
- Employees paid over £60,000: 1 (£150,001–£200,000: 1)
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/10/2023
- Volunteers: 50
- Employees paid over £60,000: 1 (£150,001–£200,000: 1)
- Grant-making is its main activity
Structured financials (annual return, FY ending 31/10/2025)
Trustees
- Alston Owens
- DR Guy Edward Dickens Pratt
- Dr Priyanka Mehta
- Geoffrey William Cousins
- Joanne Claire Murphy
- Laura Manning Shoaf CBE
- PROFESSOR CHARLES FRANK CRADDOCK
- Philip Mark Whitehead
- Sarah Margaret Hope
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/10/2025 | £3.7m | £3.6m |
| 31/10/2024 | £2.9m | £2.9m |
| 31/10/2023 | £2.9m | £3.0m |
| 31/10/2022 | £2.7m | £2.3m |
| 31/10/2021 | £2.3m | £2.3m |
Common questions
Is CURE LEUKAEMIA financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net surplus of £105,278 for the year ended 31 October 2025, with total unrestricted funds carried forward amounting to £563,068. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and believe no material uncertainties exist regarding going concern. The charity's reserves policy aims to maintain free reserves equivalent to between 6 and 12 months of unrestricted expenditure. Its FY2025 accounts were audited by JW Hinks LLP.
Who funds CURE LEUKAEMIA?
Funders whose own accounts filings name CURE LEUKAEMIA as a grant recipient include THE PENNIES FOUNDATION, THE 29TH MAY 1961 CHARITY, BNA CHARITABLE INCORPORATED ORGANISATION, THE SYNCONA FOUNDATION, THE ROAN CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE PENNIES FOUNDATION | FY2023 | Unverified read£51k | |
| THE PENNIES FOUNDATION | FY2024 | £44k | |
| THE PENNIES FOUNDATION | FY2025 | Unverified read£43k | Grant to institution |
| THE 29TH MAY 1961 CHARITY | FY2022 | £30k | costs of a trials coordinator at their centre in Birmingham |
| BNA CHARITABLE INCORPORATED ORGANISATION | FY2023 | £25k | |
| THE SYNCONA FOUNDATION | FY2024 | £20k | |
| THE ROAN CHARITABLE TRUST | FY2022 | £10k | Relief of persons suffering from leukaemia |
| WSH FOUNDATION | FY2025 | £8k | funds research and life-saving treatment support at blood cancer centres across the United Kingdom. |
| THE NOEL SWEENEY FOUNDATION | FY2023 | Unverified read£5k | |
| THE ROAN CHARITABLE TRUST | FY2021 | £5k | Relief of persons suffering from leukaemia by funding new therapies, treatments and research into and trials of such treatments and providing personnel and faci |
| FARRER AND CO CHARITABLE TRUST | FY2025 | £4k | |
| SSP FOUNDATION | FY2021 | £1k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE FIDELITY UK FOUNDATION | 1 | £94k |
| CECIL AND HILDA LEWIS CHARITABLE TRUST | 1 | £18k |
| THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATION | 1 | £17k |
| THE GRAND CHARITY | 1 | £10k |
| THE LIZ AND TERRY BRAMALL FOUNDATION | 1 | £10k |
| BOOTS CHARITABLE TRUST | 1 | £9k |
| THE EDWARD AND DOROTHY CADBURY TRUST | 1 | £9k |
| FRAZER TRUST | 1 | £8k |
Charities like this
- LEUKAEMIA CARE
- CANCER CARE AND HAEMATOLOGY FUND
- TOPIC OF CANCER
- NOTTINGHAMSHIRE LEUKAEMIA APPEAL
- LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES)
- LEUKAEMIA RESEARCH APPEAL FOR WALES
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |
| LEUKAEMIA CARE | £2.5m | — | — | above | — | no doubt |
| CANCER CARE AND HAEMATOLOGY FUND | £108k | — | 0 | unclear | — | no doubt |
| TOPIC OF CANCER | £157k | — | 0 | above | — | no doubt |
| NOTTINGHAMSHIRE LEUKAEMIA APPEAL | £45k | — | — | unclear | — | no doubt |
| LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES) | £49k | — | 0 | unclear | — | no doubt |